Gainers Redhill Biopharma (NASDAQ:RDHL) stock increased by 69.4% to $1.12 during Monday's regul

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys

Tenax Therapeutics, Inc. (NASDAQ:TENX) ("Tenax" or "Tenax Therapeutics" or the "

In patients with a baseline 6MWD below the trial median of 333 meters, treatment with TNX-103 result

Gainers Picard Medical (AMEX:PMI) shares moved upwards by 82.7% to $9.38 during Tuesday's regul

Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 35.9% to $7.3 during Tuesday's

Tenax Therapeutics (TENX) Securities Investigation Notice - Levi and Korsinsky PR Newswire NEW YORK,

Tenax Therapeutics shares fell approximately 84% to 85% after the Company disclosed that its Phase 3

Tenax Therapeutics shares lost roughly 84% to 85% of their value after the Company disclosed that it

[url="]Schall, Brown and Schwartz[/url] LLP (“SBS”), a national shareholder rights litigation fi

LOS ANGELES--(BUSINESS WIRE)---- $TENX--TENX Investors Have Opportunity to Join Tenax Therapeutics,

A single clinical readout drove Tenax Therapeutics (NASDAQ: TENX) shares down approximately 84% to 8

NEW YORK--(BUSINESS WIRE)--A single clinical readout drove Tenax Therapeutics (NASDAQ: TENX) shares

Tenax Therapeutics stock lost approximately 84% to 85% of its value in a single trading session afte

Tenax Therapeutics shareholders were left holding a substantially lower-valued stock after the Phase

Chardan Capital analyst Gautam Chukka downgrades Tenax Therapeutics (NASDAQ:TENX) from Buy to Neu

Guggenheim analyst Seamus Fernandez maintains Tenax Therapeutics (NASDAQ:TENX) with a Buy and low

Evercore ISI Group analyst Gavin Clark-Gartner downgrades Tenax Therapeutics (NASDAQ:TENX) from O

Tenax Therapeutics NASDAQ: TENX reported that its Phase III LEVEL trial of oral levosimendan in pati

Gainers Jin Medical International (NASDAQ:ZJYL) shares rose 58.1% to $3.4 during Monday's regul

US stocks mixed, Dow Jones down 0.2% midday. Energy shares up 3%, real estate down 1.4%. National En

Tenax Therapeutics Inc. (NASDAQ:TENX) stock is trading lower on Monday after the company reported to

Tenax Therapeutics announced Phase 3 LEVEL trial results for TNX-103, missing primary endpoints whil

Tenax Therapeutics, Inc. (TENX) Discusses Phase III LEVEL Trial Results for Oral Levosimendan in HFp

Dow Jones fell 0.2% as US stocks opened lower. Energy shares rose 1.9%, while real estate stocks dro

Gainers Jin Medical International (NASDAQ:ZJYL) stock rose 70.7% to $3.67 during Monday's pre-m

Summary: U.S. stock futures mixed, Dow futures down 0.1%. AirSculpt Technologies shares fell 13.4% a

Tenax ​Therapeutics said on ‌Monday its experimental heart drug failed to meet the ​main goal of ​a

TNX-103 did not meet statistical significance on the primary endpoint of improvement in 6-minute wal

TNX-103 did not meet statistical significance on the primary endpoint of improvement in 6-minute wal

Tenax Therapeutics, Inc. (NASDAQ: TENX - Get Free Report) has received a consensus recommendation of

Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.35) per share which beat the analy

Company expects to report topline data from Phase 3 LEVEL clinical trial in August 2026 CHAPEL HILL,

Canaccord Genuity analyst Whitney Ijem initiates coverage on Tenax Therapeutics (NASDAQ:TENX) wit

Evercore ISI Group analyst Gavin Clark-Gartner initiates coverage on Tenax Therapeutics (NASDAQ:T

The mean of analysts' price targets for Tenax Therapeutics (TENX) points to a 121.4% upside in the s

Tenax Therapeutics, Inc. is downgraded from Buy to Hold ahead of a major August 2026 phase 3 data re

CHAPEL HILL, N.C., July 02, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax

Rivian Automotive Inc (RIVN) gained 12.2% after strong Q2 production figures and raised delivery for

Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 40.9% to $0.16 during Thursday's pre-

Abstract recently submitted in anticipation of initial data analysis ahead of ESCCompany expects to

Cantor Fitzgerald analyst Olivia Brayer Saunders reiterates Tenax Therapeutics (NASDAQ:TENX) with

Guggenheim analyst Seamus Fernandez maintains Tenax Therapeutics (NASDAQ:TENX) with a Buy and rai

Chardan Capital analyst Gautam Chukka initiates coverage on Tenax Therapeutics (NASDAQ:TENX) with

Piper Sandler analyst Yasmeen Rahimi maintains Tenax Therapeutics (NASDAQ:TENX) with a Overweight

Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(0.35) per share which beat the analy

https://www.sec.gov/Archives/edgar/data/34956/000165495426002661/tennx_s3.htm

Top Wall Street analysts changed outlook on top names. See full changes, upgrades, downgrades and in

Cantor Fitzgerald analyst Olivia Brayer Saunders initiates coverage on Tenax Therapeutics (NASDAQ